Since the discovery of C9orf72 in 2011, it has therefore gradually become clear that significant variability of penetrance exists for the phenotypes associated with this mutation and that modifying mutations and variants in other ALS/FTD-related genes are often additionally present in affected expansion-positive patients [6]. Here, C9orf72 is linked to frontotemporal dementia.